These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30686589)

  • 1. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy.
    Xie X; Wu H; Li M; Chen X; Xu X; Ni W; Lu C; Ni R; Bao B; Xiao M
    Cytotherapy; 2019 May; 21(5):509-524. PubMed ID: 30686589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment.
    Massey AE; Malik S; Sikander M; Doxtater KA; Tripathi MK; Khan S; Yallapu MM; Jaggi M; Chauhan SC; Hafeez BB
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy.
    Zhao W; Li K; Li L; Wang R; Lei Y; Yang H; Sun L
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy.
    Kourembanas S
    Annu Rev Physiol; 2015; 77():13-27. PubMed ID: 25293529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes from different cells: Characteristics, modifications, and therapeutic applications.
    Li M; Li S; Du C; Zhang Y; Li Y; Chu L; Han X; Galons H; Zhang Y; Sun H; Yu P
    Eur J Med Chem; 2020 Dec; 207():112784. PubMed ID: 33007722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
    Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of exosomes as nanocarriers in cancer therapy.
    Hu J; Zhu J; Chai J; Zhao Y; Luan J; Wang Y
    J Mater Chem B; 2023 Nov; 11(44):10595-10612. PubMed ID: 37927220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell-Derived Exosomes and Their Potential Agents in Hematological Diseases.
    Shen M; Chen T
    Oxid Med Cell Longev; 2021; 2021():4539453. PubMed ID: 34621464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
    Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
    J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
    Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
    Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
    [No Abstract]   [Full Text] [Related]  

  • 13. Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer.
    Heidari R; Gholamian Dehkordi N; Mohseni R; Safaei M
    J Drug Target; 2020; 28(7-8):732-741. PubMed ID: 32463709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward.
    Zhang YF; Shi JB; Li C
    Cytotherapy; 2019 Nov; 21(11):1122-1136. PubMed ID: 31699595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy.
    Liu H; Deng S; Han L; Ren Y; Gu J; He L; Liu T; Yuan ZX
    Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 1):112163. PubMed ID: 34736220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts.
    Cho JA; Park H; Lim EH; Kim KH; Choi JS; Lee JH; Shin JW; Lee KW
    Gynecol Oncol; 2011 Nov; 123(2):379-86. PubMed ID: 21903249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-derived mesenchymal stem cell exosomes: a novel pathway for tissues repair.
    Fang Y; Zhang Y; Zhou J; Cao K
    Cell Tissue Bank; 2019 Jun; 20(2):153-161. PubMed ID: 30852701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GMP-Compliant Mesenchymal Stem Cell-Derived Exosomes for Cell-Free Therapy in Cancer.
    Arjmand B; Alavi-Moghadam S; Rezaei-Tavirani M; Kokabi-Hamidpour S; Arjmand R; Gilany K; Rajaeinejad M; Rahim F; Namazi N; Larijani B
    Methods Mol Biol; 2024; 2736():163-176. PubMed ID: 36515892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Role of Mesenchymal Stem Cell-derived Exosomes in Regenerative Medicine.
    Zhao T; Sun F; Liu J; Ding T; She J; Mao F; Xu W; Qian H; Yan Y
    Curr Stem Cell Res Ther; 2019; 14(6):482-494. PubMed ID: 30819086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.